Replies to post #176651 on Anavex Life Sciences Corp (AVXL)

[plexrec]

Biostock--" but again recall why did we get this information at this time and the source?" and the answer is ???? Thanks for your contributions !!!!

[nidan7500]

Biostockclub:

again recall why did we get this information at this time and the source?

Thank you again for strong words and insights. It almost seems like the delays we live with as AVXL shareholders are baked into the process long before they are relevant or known. (we don't know what we don't know) I have been convinced for a long time that Dr. M is way down the road. This patent thing will rumble around for a while as an indicator of iceberg peekaboo, eventually we get to see the whole thing.

I am pleased about this patent release b/c it pulls back the curtain for me on how the Precision Medicine structured approach using the AI tool suite has guided us. It does appear that the AI tool/Biomarker process interaction will provide us will enough true causal effect information on AD. It may get cloudy and fuzzy from one day to the next but in my experience that is how/when learning happens. Instead of being off in the weeds with the Amyloid thesis guys A2-73 can be discussed w/facts and knowledge. There will be an AAAHHHAAA moment for AD patients. And, we should be looking forward to similar process steps for other CNS diseases. IMO, this path will take us where we want to go soon. When the Rest of the world (ROW) sees a product/process that works then Right To try,(RTT) RWE/RWD/QOL will avalanche support.

As you said,

This looks like a balancing act of keeping the cells under enough of a mild stress state to prioritize cortisol production, then, when that drops off as homeostasis is recognized by the body’s sensors, switch off the remedy, long enough to put it back into a mild stress state. The device could help monitor those levels easily.

Thanks again for your time and thoughts.BR